C&EN: Artificial intelligence finds alternative routes to COVID-19 drug candidates

If drug-repurposing studies hit pay dirt, backup recipes could help antiviral manufacturers avoid supply chain problems.

This entry was posted in Highlights. Bookmark the permalink.